Edward Kim, MD, Oncology, Charlotte, NC, Atrium Health's Carolinas Medical Center

EdwardS.KimMD

Oncology Charlotte, NC

Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Chair, Solid Tumor Oncology and Investigational Therapeutics, Levine Cancer Institute, Carolinas HealthCare System

Dr. Kim is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kim's full profile

Already have an account?

Education & Training

  • University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer CenterFELLOWSHIP
  • Baylor College of Medicine
    Baylor College of MedicineRESIDENCY
  • Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2021
  • TX State Medical License
    TX State Medical License 1998 - 2022
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase 2 study of brigatinib in patients (pts) with anaplastic lymphoma kinase (ALK)-positive, advanced non-small cell lung cancer (NSCLC) that progressed on alectinib ... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Barriers to clinical trial accrual: Clinical trialists' perspectives. 
    2019 ASCO Annual Meeting - 6/1/2019
  • 94th Annual Meeting of American Radium Society 
    American Radium Society, Las Vegas, Nevada - 4/28/2012

Press Mentions

  • Movement to Broaden Inclusivity for Oncology Clinical Trials or at Least Clinically Rationalize Your Exclusion Criteria
    Movement to Broaden Inclusivity for Oncology Clinical Trials or at Least Clinically Rationalize Your Exclusion CriteriaOctober 26, 2019
  • ASCO Direct™ Highlights
    ASCO Direct™ HighlightsJune 03, 2019
  • Emergence of Immunotherapy for Small Cell Lung Cancer
    Emergence of Immunotherapy for Small Cell Lung CancerMay 16, 2019
  • Join now to see all

Grant Support

  • Early Therpeutics with Phase II EmphasisNIH/NCI2012–2016
  • Personalizing NSCLC Therapy: Exploiting KRAS Activated PathwaysNIH/NCI2010–2015
  • U10 Full Member Application Affiliated with SWOGNIH/NCI2011–2012

Professional Memberships

Hospital Affiliations